Adamis Pharmaceuticals Corp (ADMP)


Stock Price Forecast

Sept. 18, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Adamis Pharmaceuticals Corp chart...

About the Company

adamis pharmaceuticals corporation (nasdaq: admp) is a specialty biopharmaceuticals company focused on developing and commercializing products in the therapeutic areas of respiratory disease, allergies, oncology and immunology. its specialty pharmaceutical division currently has four products in its pipeline including the epinephrine injection pre-filled syringe (pfs) for use in the emergency treatment of anaphylaxis, apc-1000 and apc-5000 (dry powder inhaler) for the treatment of asthma and chronic obstructive pulmonary disease (copd), and apc-3000, a hydrofluoroalkane (hfa) inhaled nasal steroid product for the treatment of allergic rhinitis. this division’s focus is to create low cost therapeutic alternatives to existing treatments in large markets. adamis will pursue 505(b)(2) regulatory approval filings in order to minimize costs and shorten the time to market in this division. within its biotechnology division, the company has four products under development include telob-vax, a

$5M

Total Revenue

71K

Employees

$2M

Market Capitalization

-0.54

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ADMP News

Adamis Pharmaceuticals Corp (CY3.MU)

19d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

David C. Benedicto's Net Worth

22d ago, source: Benzinga.com

Who is David C. Benedicto? David C. Benedicto does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Adamis Pharmaceuticals Corp.

DMK Pharmaceuticals Corp (DMKPQ)

7d ago, source: Investing

DMK Pharmaceuticals Corporation, based in San Diego, disclosed a third-quarter net loss of $1.4 million today. The biopharmaceutical company reported a loss of 20 cents per share, ...

Meera J. Desai's Net Worth

22d ago, source: Benzinga.com

Who is Meera J. Desai? Meera J. Desai does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Adamis Pharmaceuticals Corp.

Jannine Versi's Net Worth

22d ago, source: Benzinga.com

Jannine Versi does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Adamis Pharmaceuticals Corp.

DMK Pharmaceuticals Corp DMKPQ

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

DMK Pharmaceuticals Corp DMKPQ

21d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...